Journal: BMC Infectious Diseases

Article Title: Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis

doi: 10.1186/s12879-016-1931-2

Figure Lengend Snippet: Characteristics and Quality assessment of studies included in the review

Article Snippet: Eight electronic databases were searched for field studies published between January 2005 and January 2015 of six POC CD4 platforms: PointCare NOWTM, Alere PimaTM CD4, DaktariTM CD4 Counter, CyFlow® CD4 miniPOC, BD FACSPrestoTM, and MyT4TM CD4.

Techniques: Comparison, Infection, Flow Cytometry, Western Blot

Journal: BMC Infectious Diseases

Article Title: Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis

doi: 10.1186/s12879-016-1931-2

Figure Lengend Snippet: Performance of Pima stratified by venous and capillary blood collection and presented by reference test used

Article Snippet: Eight electronic databases were searched for field studies published between January 2005 and January 2015 of six POC CD4 platforms: PointCare NOWTM, Alere PimaTM CD4, DaktariTM CD4 Counter, CyFlow® CD4 miniPOC, BD FACSPrestoTM, and MyT4TM CD4.

Techniques: Flow Cytometry

Journal: BMC Infectious Diseases

Article Title: Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis

doi: 10.1186/s12879-016-1931-2

Figure Lengend Snippet: Point estimates ‡ of diagnostics performance of Pima in field settings at CD4 350 cells/μl cut-off

Article Snippet: Eight electronic databases were searched for field studies published between January 2005 and January 2015 of six POC CD4 platforms: PointCare NOWTM, Alere PimaTM CD4, DaktariTM CD4 Counter, CyFlow® CD4 miniPOC, BD FACSPrestoTM, and MyT4TM CD4.

Techniques:

Journal: BMC Infectious Diseases

Article Title: Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis

doi: 10.1186/s12879-016-1931-2

Figure Lengend Snippet: HSROC curve from multi-level bivariate random effects model estimation of diagnostic performance of Pima at CD4 350 cells/μ cut-off ¥ : plots observed sensitivity and specificity, diagnostic summary point, 95 % confidence and prediction contours.

Article Snippet: Eight electronic databases were searched for field studies published between January 2005 and January 2015 of six POC CD4 platforms: PointCare NOWTM, Alere PimaTM CD4, DaktariTM CD4 Counter, CyFlow® CD4 miniPOC, BD FACSPrestoTM, and MyT4TM CD4.

Techniques: Diagnostic Assay

Journal: International Journal of Nanomedicine

Article Title: Advancements in nano-enabled therapeutics for neuroHIV management

doi: 10.2147/IJN.S109943

Figure Lengend Snippet: A performance summary of available diagnostic tests/tools used to detect HIV infection

Article Snippet: • Portable CD4 + T-cell count (PointCare NOW, CyFlow miniPOC) , • Blood (90%/96%).

Techniques: Diagnostic Assay, Biomarker Discovery, Enzyme-linked Immunosorbent Assay, Activity Assay, Reverse Transcription Polymerase Chain Reaction, Clinical Proteomics, Antigen Assay

Journal: African Journal of Laboratory Medicine

Article Title: Establishing a national laboratory quality system for HIV diagnosis and monitoring in resource-limited settings: Experience from Senegal

doi: 10.4102/ajlm.v5i2.440

Figure Lengend Snippet: Existing technologies or platforms HIV diagnosis, CD4 count, and viral load monitoring at each level of the tiered health system in Senegal.

Article Snippet: LBV/CADU , - , HIV rapid diagnostic test and confirmation CD4 count. Viral load monitoring and early infant diagnosis. Validating diagnostic testing. Validating POC testing. Coordination, supervision and quality assurance. Proficiency testing. , BD FacsCount ® . Apogee Auto40 ® . BD FacsCalibur ® . Pima CD4 ® . Coulter ® Cyflow counter ® Point care Now ® . Millipore Guava ® . Cyflow ® Minipoc ® , Cobas TaqMan ® . Abbott m 2000 ® . NucliSENS Easy Q V2.0 ® . NucliSENS Easy Mag ® NucliSENS MiniMag ® , -.

Techniques: Diagnostic Assay

Journal: African Journal of Laboratory Medicine

Article Title: Establishing a national laboratory quality system for HIV diagnosis and monitoring in resource-limited settings: Experience from Senegal

doi: 10.4102/ajlm.v5i2.440

Figure Lengend Snippet: Existing technologies or platforms HIV diagnosis, CD4 count, and viral load monitoring at each level of the tiered health system in Senegal.

Article Snippet: LBV/CADU , - , HIV rapid diagnostic test and confirmation CD4 count. Viral load monitoring and early infant diagnosis. Validating diagnostic testing. Validating POC testing. Coordination, supervision and quality assurance. Proficiency testing. , BD FacsCount ® . Apogee Auto40 ® . BD FacsCalibur ® . Pima CD4 ® . Coulter ® Cyflow counter ® Point care Now ® . Millipore Guava ® . Cyflow ® Minipoc ® , Cobas TaqMan ® . Abbott m 2000 ® . NucliSENS Easy Q V2.0 ® . NucliSENS Easy Mag ® NucliSENS MiniMag ® , -.

Techniques: Diagnostic Assay

Journal: BMC Health Services Research

Article Title: Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries: a systematic review

doi: 10.1186/s12913-016-1588-y

Figure Lengend Snippet: Characteristics of studies included in the review

Article Snippet: For intervention (I), any of the following six commercially available POC CD4 testing platforms listed in the UNITAID “2014 HIV/AIDS Diagnosis Technology Landscape” report [ ] were included: (1) PointCare NOW™ (PointCare Technology Inc, Marlborough, MA, USA); (2) Pima™ CD4 (Alere Inc, Waltham, MA, USA); (3) Daktari™ CD4 Counter (Daktari Diagnostics Inc, Cambridge MA, USA); (4) CyFlow® CD4 miniPOC (Partec, Munich, Germany); (5) BD FACSPresto™ (BD Biosciences, San Jose, CA, USA); and (6) MyT4™ CD4 Test (Zyomyx Inc, Fremont, CA, USA).

Techniques: Infection, Western Blot

Journal: BMC Health Services Research

Article Title: Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries: a systematic review

doi: 10.1186/s12913-016-1588-y

Figure Lengend Snippet: Acceptability and feasibility of POC CD4 test

Article Snippet: For intervention (I), any of the following six commercially available POC CD4 testing platforms listed in the UNITAID “2014 HIV/AIDS Diagnosis Technology Landscape” report [ ] were included: (1) PointCare NOW™ (PointCare Technology Inc, Marlborough, MA, USA); (2) Pima™ CD4 (Alere Inc, Waltham, MA, USA); (3) Daktari™ CD4 Counter (Daktari Diagnostics Inc, Cambridge MA, USA); (4) CyFlow® CD4 miniPOC (Partec, Munich, Germany); (5) BD FACSPresto™ (BD Biosciences, San Jose, CA, USA); and (6) MyT4™ CD4 Test (Zyomyx Inc, Fremont, CA, USA).

Techniques: Sampling, Diagnostic Assay, High Throughput Screening Assay